159 related articles for article (PubMed ID: 30672305)
1. The intricate role of miR-155 in carcinogenesis: potential implications for esophageal cancer research.
Nariman-Saleh-Fam Z; Saadatian Z; Daraei A; Mansoori Y; Bastami M; Tavakkoli-Bazzaz J
Biomark Med; 2019 Feb; 13(2):147-159. PubMed ID: 30672305
[TBL] [Abstract][Full Text] [Related]
2. MiR-139-5p regulates VEGFR and downstream signaling pathways to inhibit the development of esophageal cancer.
Jiao W; Zhang J; Wei Y; Feng J; Ma M; Zhao H; Wang L; Jiao W
Dig Liver Dis; 2019 Jan; 51(1):149-156. PubMed ID: 30245290
[TBL] [Abstract][Full Text] [Related]
3. MicroRNAs in esophageal squamous cell carcinoma: Potential biomarkers and therapeutic targets.
Mei LL; Qiu YT; Zhang B; Shi ZZ
Cancer Biomark; 2017; 19(1):1-9. PubMed ID: 28269750
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-6869-5p acts as a tumor suppressor via targeting TLR4/NF-κB signaling pathway in colorectal cancer.
Yan S; Liu G; Jin C; Wang Z; Duan Q; Xu J; Xu D
J Cell Physiol; 2018 Sep; 233(9):6660-6668. PubMed ID: 29206292
[TBL] [Abstract][Full Text] [Related]
5. Methylation-mediated repression of potential tumor suppressor miR-203a and miR-203b contributes to esophageal squamous cell carcinoma development.
Liu Y; Dong Z; Liang J; Guo Y; Guo X; Shen S; Kuang G; Guo W
Tumour Biol; 2016 Apr; 37(4):5621-32. PubMed ID: 26577858
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-367 is a potential diagnostic biomarker for patients with esophageal squamous cell carcinoma.
Sun J; Song K; Feng X; Gao S
Biochem Biophys Res Commun; 2016 Apr; 473(2):363-9. PubMed ID: 26777997
[TBL] [Abstract][Full Text] [Related]
7. Primary tumor microRNA signature predicts recurrence and survival in patients with locally advanced esophageal adenocarcinoma.
Matsui D; Zaidi AH; Martin SA; Omstead AN; Kosovec JE; Huleihel L; Saldin LT; DiCarlo C; Silverman JF; Hoppo T; Finley GG; Badylak SF; Kelly RJ; Jobe BA
Oncotarget; 2016 Dec; 7(49):81281-81291. PubMed ID: 27793030
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-224: as a potential target for miR-based therapy of cancer.
Chen W; Fan XM; Mao L; Zhang JY; Li J; Wu JZ; Tang JH
Tumour Biol; 2015 Sep; 36(9):6645-52. PubMed ID: 26254100
[TBL] [Abstract][Full Text] [Related]
9. miR-675-5p enhances tumorigenesis and metastasis of esophageal squamous cell carcinoma by targeting REPS2.
Zhou YW; Zhang H; Duan CJ; Gao Y; Cheng YD; He D; Li R; Zhang CF
Oncotarget; 2016 May; 7(21):30730-47. PubMed ID: 27120794
[TBL] [Abstract][Full Text] [Related]
10. Clinical potential of miR-3651 as a novel prognostic biomarker for esophageal squamous cell cancer.
Wang C; Guan S; Chen X; Liu B; Liu F; Han L; Un Nesa E; Song Q; Bao C; Wang X; Cheng Y
Biochem Biophys Res Commun; 2015 Sep; 465(1):30-4. PubMed ID: 26210449
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-129 in Human Cancers: from Tumorigenesis to Clinical Treatment.
Gao Y; Feng B; Han S; Lu L; Chen Y; Chu X; Wang R; Chen L
Cell Physiol Biochem; 2016; 39(6):2186-2202. PubMed ID: 27802440
[TBL] [Abstract][Full Text] [Related]
12. MiR-498 in esophageal squamous cell carcinoma: clinicopathological impacts and functional interactions.
Islam F; Gopalan V; Law S; Tang JC; Chan KW; Lam AK
Hum Pathol; 2017 Apr; 62():141-151. PubMed ID: 28188753
[TBL] [Abstract][Full Text] [Related]
13. MiR-26a and miR-144 inhibit proliferation and metastasis of esophageal squamous cell cancer by inhibiting cyclooxygenase-2.
Shao Y; Li P; Zhu ST; Yue JP; Ji XJ; Ma D; Wang L; Wang YJ; Zong Y; Wu YD; Zhang ST
Oncotarget; 2016 Mar; 7(12):15173-86. PubMed ID: 26959737
[TBL] [Abstract][Full Text] [Related]
14. Tumor suppressor microRNA-34a inhibits cell migration and invasion by targeting MMP-2/MMP-9/FNDC3B in esophageal squamous cell carcinoma.
Yang L; Song X; Zhu J; Li M; Ji Y; Wu F; Chen Y; Cui X; Hu J; Wang L; Cao Y; Wei Y; Zhang W; Li F
Int J Oncol; 2017 Jul; 51(1):378-388. PubMed ID: 28534990
[TBL] [Abstract][Full Text] [Related]
15. Analysis of microRNA (miRNA) expression profiles reveals 11 key biomarkers associated with non-small cell lung cancer.
Wang K; Chen M; Wu W
World J Surg Oncol; 2017 Sep; 15(1):175. PubMed ID: 28927412
[TBL] [Abstract][Full Text] [Related]
16. STAT3 is involved in miR-124-mediated suppressive effects on esophageal cancer cells.
Cheng Y; Li Y; Nian Y; Liu D; Dai F; Zhang J
BMC Cancer; 2015 Apr; 15():306. PubMed ID: 25928665
[TBL] [Abstract][Full Text] [Related]
17. Serum-based six-miRNA signature as a potential marker for EC diagnosis: Comparison with TCGA miRNAseq dataset and identification of miRNA-mRNA target pairs by integrated analysis of TCGA miRNAseq and RNAseq datasets.
Sharma P; Saraya A; Sharma R
Asia Pac J Clin Oncol; 2018 Oct; 14(5):e289-e301. PubMed ID: 29380534
[TBL] [Abstract][Full Text] [Related]
18. Identification of miR-375 as a potential prognostic biomarker for esophageal squamous cell cancer: A bioinformatics analysis based on TCGA and meta-analysis.
Luo HS; Wu DH
Pathol Res Pract; 2019 Mar; 215(3):512-518. PubMed ID: 30638952
[TBL] [Abstract][Full Text] [Related]
19. Regulation of SPOCK1 by dual strands of pre-miR-150 inhibit cancer cell migration and invasion in esophageal squamous cell carcinoma.
Osako Y; Seki N; Koshizuka K; Okato A; Idichi T; Arai T; Omoto I; Sasaki K; Uchikado Y; Kita Y; Kurahara H; Maemura K; Natsugoe S
J Hum Genet; 2017 Nov; 62(11):935-944. PubMed ID: 28659612
[TBL] [Abstract][Full Text] [Related]
20. Integrated Analysis and MicroRNA Expression Profiling Identified Seven miRNAs Associated With Progression of Oral Squamous Cell Carcinoma.
Yan ZY; Luo ZQ; Zhang LJ; Li J; Liu JQ
J Cell Physiol; 2017 Aug; 232(8):2178-2185. PubMed ID: 27935034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]